SCHEMBL22859043

SCHEMBL22859043

COc1cc(-c2cnc3c(n2)c(-c2ccc(C(=O)N(C)C)cc2)cn3SI)cc2c1CN(CC(C)(C)O)CC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 4/20 0.36
▸ TTK P33981 2/20 0.36
▸ JAK2 O60674 6/20 0.35
▸ JAK1 P23458 6/20 0.35
▸ TYK2 P29597 5/20 0.35
▸ JAK3 P52333 5/20 0.35
▸ PARP1 P09874 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ ATR Q13535 3/20 0.32
▸ HTR1A P08908 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31
▸ MKNK1 Q9BUB5 1/20 0.31
▸ MKNK2 Q9HBH9 1/20 0.31
▸ CYP11B2 P19099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29607735 0.85 MAP4K1 (0.34) MAP4K1TTKJAK2JAK1TYK2
SCHEMBL29609161 0.84 MAP4K1 (0.51) MAP4K1TTKJAK2JAK1TYK2
SCHEMBL22858746 0.84 MAP4K1 (0.51) MAP4K1TTKJAK2JAK1TYK2
SCHEMBL22859028 0.83 MAP4K1 (0.41) MAP4K1TTKJAK2JAK1TYK2
SCHEMBL22858982 0.82 MAP4K1 (0.40) MAP4K1JAK2JAK1TYK2JAK3
SCHEMBL24954494 0.81 MAP4K1 (0.43) MAP4K1JAK2JAK1TYK2JAK3
SCHEMBL24954317 0.79 MAP4K1 (0.41) MAP4K1
SCHEMBL22858885 0.79 MAP4K1 (0.45) MAP4K1JAK2JAK1TYK2JAK3
SCHEMBL22858749 0.77 MAP4K1 (0.38) MAP4K1JAK2JAK1TYK2JAK3
SCHEMBL22859186 0.75 MAP4K1 (0.45) MAP4K1JAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021000925-A1 PYRROLO [2, 3-b] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2021-01-07 — — WO disclosed
Send feedback